Jane Street’s VanEck Biotech ETF BBH Stock Holding History

Jane Street’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,200	Closed	-$227K	–	11564
2025 Q4	$227K	Sell	1,200 -800	-40%	-$148K	﹤0.01%	9463
2025 Q3	$331K	Buy	+2,000	New	+$326K	﹤0.01%	8705
2025 Q2	–	Sell	-4,187	Closed	-$659K	–	9612
2025 Q1	$659K	Buy	+4,187	New	+$680K	﹤0.01%	6357
2024 Q4	–	Sell	-8,348	Closed	-$1.48M	–	9373
2024 Q3	$1.48M	Buy	8,348 +6,684	+402%	+$1.19M	﹤0.01%	5071
2024 Q2	$280K	Sell	1,664 -10,164	-86%	-$1.66M	﹤0.01%	7904
2024 Q1	$1.97M	Buy	11,828 +9,512	+411%	+$1.58M	﹤0.01%	4158
2023 Q4	$383K	Sell	2,316 -323	-12%	-$49.7K	﹤0.01%	7238
2023 Q3	$411K	Buy	2,639 +30	+1%	+$4.79K	﹤0.01%	6579
2023 Q2	$407K	Buy	2,609 +697	+36%	+$111K	﹤0.01%	6640
2023 Q1	$310K	Sell	1,912 -241	-11%	-$39K	﹤0.01%	7141
2022 Q4	$344K	Buy	+2,153	New	+$341K	﹤0.01%	6781
2021 Q4	–	Sell	-1,000	Closed	-$202K	–	10046
2021 Q3	$202K	Buy	+1,000	New	+$210K	﹤0.01%	8817
2020 Q1	–	Sell	-20,160	Closed	-$2.81M	–	5292
2019 Q4	$2.81M	Buy	20,160 +9,779	+94%	+$1.29M	﹤0.01%	1570
2019 Q3	$1.23M	Buy	+10,381	New	+$1.29M	﹤0.01%	2358
2019 Q2	–	Sell	-1,984	Closed	-$245K	–	5124
2019 Q1	$255K	Sell	1,984 -12,371	-86%	-$1.56M	﹤0.01%	4424
2018 Q4	$1.59M	Buy	14,355 +3,525	+33%	+$426K	﹤0.01%	1995
2018 Q3	$1.47M	Buy	10,830 +9,042	+506%	+$1.18M	﹤0.01%	2261
2018 Q2	$215K	Sell	1,788 -10,023	-85%	-$1.18M	﹤0.01%	4486
2018 Q1	$1.42M	Buy	11,811 +1,229	+12%	+$154K	﹤0.01%	2241
2017 Q4	$1.32M	Buy	10,582 +8,349	+374%	+$1.07M	﹤0.01%	2009
2017 Q3	$300K	Sell	2,233 -3	-0.1%	-$391	﹤0.01%	3687
2017 Q2	$281K	Sell	2,236 -6,880	-75%	-$830K	﹤0.01%	3664
2017 Q1	$1.08M	Buy	9,116 +6,966	+324%	+$815K	﹤0.01%	1978
2016 Q4	$231K	Sell	2,150 -10,916	-84%	-$1.19M	﹤0.01%	3608
2016 Q3	$1.5M	Buy	13,066 +7,901	+153%	+$900K	0.01%	1494
2016 Q2	$529K	Sell	5,165 -8,626	-63%	-$920K	﹤0.01%	2707
2016 Q1	$1.43M	Sell	13,791 -15	-0.1%	-$1.56K	0.01%	1504
2015 Q4	$1.75M	Sell	13,806 -12,168	-47%	-$1.49M	0.01%	1205
2015 Q3	$2.97M	Buy	25,974 +20,661	+389%	+$2.73M	0.02%	710
2015 Q2	$716K	Sell	5,313 -26,934	-84%	-$3.58M	﹤0.01%	1919
2015 Q1	$4.18M	Buy	+32,247	New	+$4.05M	0.03%	486
2014 Q4	–	Sell	-3,924	Closed	-$415K	–	2471
2014 Q3	$415K	Buy	+3,924	New	+$397K	﹤0.01%	1610
2014 Q2	–	Sell	-5,517	Closed	-$495K	–	2546
2014 Q1	$502K	Buy	+5,517	New	+$536K	0.01%	1556

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Jane Street's BBH Position: Q1 2026 in Review

Jane Street sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 1,200 shares — an estimated $227K sold.

Jane Street first reported a position in BBH in Q1 2014 and held it in 33 quarters. The position peaked at $4.18M in Q1 2015. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Jane Street reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
Jane Street sold 1,200 VanEck Biotech ETF shares in Q1 2026, an estimated $227K.
Jane Street first reported a position in VanEck Biotech ETF in Q1 2014 and held it in 33 quarters.
Jane Street's VanEck Biotech ETF position peaked at $4.18M in Q1 2015.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.